What is AGEN's health score?

AGENUS INC (AGEN) has a TradeApes health score of 46 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is AGEN's estimated fair value?

Based on our 5-year discounted cash flow model, AGENUS INC's estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is AGEN undervalued or overvalued?

Our model currently rates AGEN as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for AGEN... Refresh in a moment for the full analysis.

AGENUS INC (AGEN)

Healthcare Inconclusive inconclusive mixed

$3.4

Updated: 2026-06-04

TradeApes Score

Financial Strength

35 Weak

Operating Trend

65 Healthy

Relative Value

50 Mixed

Capital Allocation

10 Stressed

Risk

65 Healthy

Key Findings

+ Strong revenue growth — sales up more than 20% year over year

Unlock Full Report →

− Significant dilution — share count up more than 5% year over year

Unlock Full Report →

1 free score card remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.